Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $146.2400 (3.23%) ($146.2400 - $146.2400) on Wed. Feb. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.82% (three month average) | RSI | 39 | Latest Price | $146.2400(3.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -14.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(54%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.41% in a week (0% probabilities). VIXM(-28%) UUP(-18%) VXX(-17%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.41% (StdDev 4.82%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $172.58 | 5 Day Moving Average | $143.19(2.13%) | 10 Day Moving Average | $157.59(-7.2%) | 20 Day Moving Average | $172.58(-15.26%) | To recent high | -32.2% | To recent low | 75.2% | Market Cap | $2.35b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |